Thus, there is currently no doubt about the involvement of autoimmune mechanisms in the development of atherosclerosis, both as inducers of inflammation and as factors that facilitate the clearance of modified Lp from the bloodstream. The gene discussed is LPA; the disease is atherosclerosis.